FDA

In the United States alone during 2019, nearly 69,000 people donated a total of 85,681 corneas for transplants that completely transformed the lives of people from being blind to having sight. More than 95 percent of those corneal transplants were…

Arkansas Research Alliance celebrated Tuesday the addition of two new ARA Scholars and six ARA Fellows to its ARA Academy of Scholars and Fellows. The Arkansas Research Alliance operates as a public-private partnership and invests in research to stimulate innovation,…

As the COVID-19 pandemic continues, medical providers are discovering new tools to battle the deadly virus. One of these tools is monoclonal antibodies, also known as mAbs. The U.S. Food and Drug Administration (FDA) has granted emergency use authorization (EUA) of two monoclonal antibody treatments…

Doctors at the University of Arkansas for Medical Sciences (UAMS) recently activated the first lung biopsy robot in Arkansas. The robot allows doctors to discover and biopsy previously undetectable cancerous nodules in the far reaches of the lungs. “This enables…

The University of Arkansas for Medical Sciences (UAMS) will begin offering third doses of the Pfizer COVID-19 vaccine to qualifying individuals on Monday, Sept. 27, at the Vaccine Clinic at 401 S. Monroe St. in Little Rock. This clinic also…

The FDA National Center for Toxicological Research (NCTR) in Jefferson celebrated its 50th anniversary and renewed its strategic partnership with the Arkansas Research Alliance this week. FDA Acting Commissioner Janet Woodcock and Gov. Asa Hutchinson signed a five-year renewal of…

Lineus Medical has been cleared to sell its first medical device, which aims to reduce mechanical complications with IV catheters. The U.S. Food and Drug Administration has cleared the Fayetteville-based medical company’s SafeBreak Vascular product for sale. The company announced…

Teenagers age 12 to 15 will now be able to obtain a Pfizer COVID-19 vaccine in Arkansas. Gov. Asa Hutchinson announced during a Tuesday afternoon press briefing that the Pfizer-BioNTech vaccine was now approved for use for 12-15 year-olds in…

The U.S. Food and Drug Administration (FDA) has authorized the Pfizer COVID-19 vaccine for teenagers 12 to 15 years of age. The federal agency expanded an existing emergency use authorization for the Pfizer-BioNTech vaccine, after determining that the vaccine met…

State officials continue to push for increased vaccinations, particularly after the Johnson & Johnson vaccine is reintroduced for distribution and use. Gov. Asa Hutchinson told reporters on Tuesday, April 27 that there is an ample supply of COVID-19 vaccine doses…